RECRUITING

A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania

Description

The purpose of this study is to learn more about the challenges with breast cancer diagnosis in Tanzania and the support available to improve this process.

Conditions

Breast Cancer
Talk to us

Related Conditions:

Breast Cancer

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to learn more about the challenges with breast cancer diagnosis in Tanzania and the support available to improve this process.

A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania

A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania

Condition
Breast Cancer
Intervention / Treatment

-

Contacts and Locations

New York

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States, 10065

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Breast cancer survivor, patient advocate or key healthcare personnel
  • * Key healthcare personnel are defined as hospital and laboratory leaders, pathologists, laboratory scientists and technicians, oncologists, nurses, and surgeons, with:
  • * \>12 months of employment at the affiliated institution
  • * Administrative or clinical involvement in the delivery of breast cancer care services.
  • * Age 18 years and above
  • * Permanent residents or citizens of Tanzania
  • * Participant and/or LAR willing and able to consent
  • * Fluent in Swahili and/or English by self-report
  • * Key stakeholder not residing at their particular institutions during data collection will be excluded.
  • * Age 18 years and above
  • * Permanent residents or citizens of Tanzania
  • * Received breast cancer diagnosis

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Memorial Sloan Kettering Cancer Center,

Diana Ng, MD, PRINCIPAL_INVESTIGATOR, Memorial Sloan Kettering Cancer Center

Study Record Dates

2026-04